Group 1: Target Price Increases - The companies with the highest target price increases from August 4 to August 8 are Jiuzhou Pharmaceutical and BYD, with target price increases of 60.26% and 55.20% respectively, belonging to the medical services and passenger vehicle industries [1][2] - Jiuzhou Pharmaceutical's latest target price is 29.12 yuan, while BYD's latest target prices are 161.30 yuan and 158.00 yuan from different institutions [2] Group 2: Broker Recommendations - A total of 201 listed companies received broker recommendations during the same period, with Zhongchong Co. receiving the highest number of recommendations at 26, followed by Ninebot with 14 and Changshu Bank with 12 [3][4] - The top recommended companies include Jiuzhou Pharmaceutical and BYD, which received 9 recommendations each [4] Group 3: Rating Adjustments - During the period, 11 companies had their ratings upgraded, including Xugong Machinery, which was upgraded from "Recommended" to "Strongly Recommended" by Huachuang Securities [5][6] - Conversely, 6 companies had their ratings downgraded, including Rongbai Technology, which was downgraded from "Buy" to "Hold" by Everbright Securities [6] Group 4: First Coverage - A total of 74 instances of first coverage were reported, with Beiding Co. receiving an "Increase" rating from Shanxi Securities, and several other companies receiving "Buy" ratings from Huaxin Securities [7]

值得一提的是，成都未来医学城在本次项目推进过程中展现出高效服务能力，为企业"量身定制"的厂房 建设方案更是园区持续优化营商环境的有力举措。此前，园区已针对性编制《高效办成一件事企业建设 服务手册》，使政务服务从"便捷办理"向"增值赋能"转变，有力保障了园区项目高效有序落地。"我们 始终把满足企业需求放在首位，把企业服务贯彻从项目落地到发展运营的全流程中，就是希望用优质的 营商环境让企业在未来医学城安心扎根、好好发展，与我们共同打造具有竞争力的产业生态。"成都未 来医学城负责人表示。 未来，成都未来医学城将持续推进"立园满园"行动，加速上下游配套企业聚集，打造高端医疗器械全产 线布局，为成都建设世界级生物医药产业集群和成渝地区产业协同发展贡献力量。 （文章来源：每日经济新闻） 8月7日，四川炬新一医疗科技有限公司总部基地（以下简称：炬新一）在位于成都东部新区的成都未来 医学城正式开工建设。作为区域产业生态布局的重要举措，这一关键性落子不仅标志着成都未来医学 城"全链条产业平台体系" 建设迈出重要步伐，也为成渝地区双城经济圈医疗器械产业的升级迭代注入 了强劲新动能。 据介绍，本次落户成都东部新区未来医学城的总部基 ...

Core Insights - The report highlights the significant role of CFOs in listed companies, with the total salary scale for A-share CFOs reaching 4.27 billion yuan in 2024 [1] - The average annual salary for CFOs in the medical device sector is reported to be 1.0652 million yuan [1] Salary Distribution - The top three highest-paid CFOs in the medical device industry are Zhao Yun from Mindray Medical with 8.4134 million yuan, Liu Lihua from Yuyue Medical with 4.3136 million yuan, and Jing Xiaokuan from Wandong Medical with 1.6412 million yuan [1] - The salary distribution among CFOs shows that 31% earn below 500,000 yuan, 43% earn between 500,000 and 1 million yuan, 20% earn between 1 million and 2 million yuan, and 6% earn above 2 million yuan [1] Age and Education Distribution - CFOs aged between 40 and 50 years constitute 54% of the total, while those over 50 years account for 35%, and those under 40 years make up 11% [1] - The educational background of CFOs reveals that 3% have an associate degree, 71% hold a bachelor's degree, 23% possess a master's degree, and only 3% have a doctoral degree, with only one CFO, Yan Hongyu from Yangpu Medical, holding a PhD [1] Salary Changes - Among CFOs with over two years of tenure, Zhang Qiu from Kangtong Medical experienced the largest salary decrease of 31.23% year-on-year, while Xu Ning from Mcland saw the highest salary increase of 165.59% year-on-year [1]

Core Insights - The report highlights the significant role of CFOs in listed companies, with the total compensation for CFOs in A-share companies reaching 4.27 billion yuan in 2024 [1] CFO Demographics - The age distribution of CFOs shows that those aged 40-50 constitute 54% of the market, while CFOs over 50 account for 35%, and those under 40 make up 11% [1] - In terms of educational background, 71% of CFOs hold a bachelor's degree, 23% have a master's degree, and only 3% possess a doctoral degree, with only one CFO, Yan Hongyu from Yangpu Medical, holding a PhD [1] Compensation Analysis - The average annual salary for CFOs in A-share medical device companies is 1.0652 million yuan [1] - The distribution of salaries shows that 31% earn below 500,000 yuan, 43% earn between 500,000 and 1 million yuan, 20% earn between 1 million and 2 million yuan, and 6% earn above 2 million yuan [1] - The top three highest-paid CFOs are Zhao Yun from Mindray Medical at 8.4134 million yuan, Liu Lihua from Yuyue Medical at 4.3136 million yuan, and Jing Xiaokuan from Wandong Medical at 1.6412 million yuan [1] Salary Changes - Among CFOs with over two years of tenure, Zhang Qiu from Kangtong Medical experienced the largest salary decrease of 31.23% year-on-year, while Xu Ning from Mcland saw the highest salary increase of 165.59% year-on-year [1]

Group 1 - The total salary scale of CFOs in A-share listed companies reached 4.27 billion yuan in 2024, with an average annual salary of 814,800 yuan [1] - In the medical device sector, the average annual salary of CFOs is 1.0652 million yuan, with 31% earning below 500,000 yuan, 43% between 500,000 and 1 million yuan, 20% between 1 million and 2 million yuan, and 6% above 2 million yuan [2] - The age distribution of CFOs shows that 54% are aged between 40 and 50, 35% are over 50, and 11% are 40 or younger, with the youngest being 30 years old and the oldest being 65 years old [1] Group 2 - The top three highest-paid CFOs in the medical device sector are Zhao Yun from Mindray Medical with 8.4134 million yuan, Liu Lihua from Yuyue Medical with 4.3136 million yuan, and Jing Xiaoqian from Wandong Medical with 1.6412 million yuan [2] - The CFO with the largest salary decrease in 2024 is Zhang Qiu from Kangtong Medical, with a year-on-year decrease of 31.23%, while Xu Ning from Mcland saw the largest increase at 165.59% [2] - The educational background of CFOs shows that 71% hold a bachelor's degree, 23% a master's degree, and only 3% hold a doctoral degree, with only one CFO having a PhD [1]

从CFO的学历分布看，拥有大专、本科、硕士、博士学历的CFO占比分别为3%、71%、23%、3%。其 中，获得博士学历的CFO仅一人，为阳普医疗的闫红玉。 专题：专题|2024年度A股CFO数据报告：美的集团钟铮年薪946万，比亚迪周亚琳896万 从薪酬分布看，A股医疗设备公司CFO年薪平均值为106.52万元。经统计，处于50万以下、50万-100 万、100万-200万、200万以上各区间的人数占比分别为31%、43%、20%、6%。 作为上市公司核心管理层关键成员，财务总监CFO的地位与作用至关重要。新浪财经《2024年度A股 CFO数据报告》显示，2024年A股上市公司财务总监CFO群体薪酬规模合计达42.70亿元，平均年薪为 81.48万元。 分行业来看，统计数据显示，剔除2024年时任CFO已离任的公司后，A股共有35家上市医疗设备公司， 其聘任总体情况如下（部分统计口径剔除无效数据）。 从CFO的年龄分布来看，40岁-50岁CFO是市场的中坚力量，占比共计达到54%；50岁以上的CFO占比 为35%；40岁及以下CFO群体占比为11%。其中，目前仍任职的最年轻的上市公司CFO年龄30岁，为博 迅 ...

专题：专题|2024年度A股CFO数据报告：美的集团钟铮年薪946万，比亚迪周亚琳896万 作为上市公司核心管理层关键成员，财务总监CFO的地位与作用至关重要。新浪财经《2024年度A股 CFO数据报告》显示，2024年A股上市公司财务总监CFO群体薪酬规模合计达42.70亿元，平均年薪为 81.48万元。 分行业来看，统计数据显示，剔除2024年时任CFO已离任的公司后，A股共有35家上市医疗设备公司， 其聘任总体情况如下（部分统计口径剔除无效数据）。 从CFO的年龄分布来看，40岁-50岁CFO是市场的中坚力量，占比共计达到54%；50岁以上的CFO占比 为35%；40岁及以下CFO群体占比为11%。其中，目前仍任职的最年轻的上市公司CFO年龄30岁，为博 迅生物的金曼；最年长上市公司CFO年龄65岁，为超研股份的陈小波。 从薪酬分布看，A股医疗设备公司CFO年薪平均值为106.52万元。经统计，处于50万以下、50万-100 万、100万-200万、200万以上各区间的人数占比分别为31%、43%、20%、6%。 其中，年薪排行前三的CFO分别为迈瑞医疗的赵云、鱼跃医疗的刘丽华、万东医疗的井晓权，三人年 ...

专题：专题|2024年度A股CFO数据报告：美的集团钟铮年薪946万，比亚迪周亚琳896万 作为上市公司核心管理层关键成员，财务总监CFO的地位与作用至关重要。新浪财经《2024年度A股 CFO数据报告》显示，2024年A股上市公司财务总监CFO群体薪酬规模合计达42.70亿元，平均年薪为 81.48万元。 从CFO的学历分布看，拥有大专、本科、硕士、博士学历的CFO占比分别为3%、71%、23%、3%。其 中，获得博士学历的CFO仅一人，为阳普医疗的闫红玉。 从薪酬分布看，A股医疗设备公司CFO年薪平均值为106.52万元。经统计，处于50万以下、50万-100 万、100万-200万、200万以上各区间的人数占比分别为31%、43%、20%、6%。 其中，年薪排行前三的CFO分别为迈瑞医疗的赵云、鱼跃医疗的刘丽华、万东医疗的井晓权，三人年薪 分别为841.34万元、431.36万元、164.12万元。 从薪酬变动幅度看（仅统计任职两年以上CFO薪资数据），2024年港通医疗的张秋薪酬降幅最大，同比 降幅达31.23%；麦澜德的徐宁薪酬增幅最大，同比涨幅达165.59%。 分行业来看，统计数据显示，剔除20 ...

Group 1 - The total salary scale of CFOs in A-share listed companies reached 4.27 billion yuan in 2024, with an average annual salary of 814,800 yuan [1] - In the medical device sector, the average annual salary of CFOs is 1.0652 million yuan, with 31% earning below 500,000 yuan, 43% between 500,000 and 1 million yuan, 20% between 1 million and 2 million yuan, and 6% earning above 2 million yuan [2] - The top three highest-paid CFOs in the medical device industry are Zhao Yun from Mindray Medical with 8.4134 million yuan, Liu Lihua from Yuyue Medical with 4.3136 million yuan, and Jing Xiaoqian from Wandong Medical with 1.6412 million yuan [2] Group 2 - The age distribution of CFOs shows that those aged 40-50 make up 54%, while 35% are over 50, and 11% are 40 or younger [1] - The educational background of CFOs indicates that 71% hold a bachelor's degree, 23% a master's degree, and only 3% have a doctoral degree, with only one CFO holding a PhD [1] - The largest salary decrease among CFOs in 2024 was observed in Zhang Qiu from Kangtong Medical, with a year-on-year decline of 31.23%, while Xu Ning from Mcland saw the largest increase at 165.59% [2]

分行业来看，统计数据显示，剔除董秘已离任公司后，A股共有37家上市医疗设备公司，其聘任总体情 况如下（部分统计口径剔除无效数据）。 从董秘的年龄分布来看，40岁-50岁的董秘是市场的中坚力量，占比共计达到44%；50岁以上的董秘占 比为25%；40岁及以下董秘群体占比为31%。其中，目前仍任职的最年轻的男上市公司董秘年龄36岁， 为康众医疗的尹晟；最年轻的女董秘年龄为32岁，为鱼跃医疗的王瑞洁。 专题：专题|2024年度A股董秘数据报告：1144位董秘年薪超百万 占比超21% 董秘作为连接投资者与上市公司的"桥梁"，在上市公司资本运作中发挥着关键作用。新浪财经《2024年 度A股董秘数据报告》显示，2024年A股上市公司董秘薪酬合计达40.86亿元，平均年薪75.43万元。 从薪酬变动幅度看，港通医疗的陈兴根2024年薪酬降幅最大，同比降幅达28.17%；瑞迈特的杜祎程薪 酬增幅最大，同比涨幅达87.43%。 责任编辑：公司观察 其中，年薪排行前五的董秘分别为迈瑞医疗的李文楣、联影医疗的TAO CAI、理邦仪器的祖幼冬、华大 智造的韦炜、鱼跃医疗的王瑞洁，五人年薪分别为738.76万元、165.11万元、16 ...